Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 3 - Aug 8
SR3335 may hold utility for suppression of elevated hepatic glucose production in type 2 diabetics
and wound healing properties
6R)-5-amino-4
InChiKey: TWHZNAUBXFZMCA-SCPKHUGHSA-N
JAK3-IN-1 possesses over 165-fold higher IC50s for BTK or ITK (IC50s = 794 and 1070 nM respectively)
O-1602 Catalog No.:M22717-C SR3335 may hold utility forO 1602 is an agonist of GPR55 (EC50 = 13 nM in a GTPS binding assay) and a derivative of the GPR55 agonist abnormal cannabidiol. It is selective for GPR55 over cannabinoid (CB) receptor 1 (CB1) and CB2 (EC50s = >30 M for both in GTPS binding assays). O 1602 (50 M) reduces growth of Mz ChA 1, HuCCT 1, CC LP 1, and SG231 cholangiocarcinoma cells and reduces tumor growth in a Mz ChA 1 mouse xenograft model when administered at a dose of 10 mg kg per day.
US$ 35.00
US$ 10.00
US$ 13.50